Fifth Third Bancorp
CYTK icon

Fifth Third Bancorp’s Cytokinetics CYTK Stock Holding History

Fifth Third Bancorp’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.58M Buy
30,303
+1,575
+5% +$113K ﹤0.01% 1132
2026
Q1 		$1.89M Buy
28,728
+27,638
+2,536% +$1.76M ﹤0.01% 1242
2025
Q4 		$69.3K Buy
1,090
+18
+2% +$1.12K ﹤0.01% 1340
2025
Q3 		$58.9K Buy
1,072
+262
+32% +$10.8K ﹤0.01% 1426
2025
Q2 		$26.8K Sell
810
-171
-17% -$5.95K ﹤0.01% 1670
2025
Q1 		$39.4K Buy
981
+291
+42% +$13.4K ﹤0.01% 1506
2024
Q4 		$32.5K Sell
690
-155
-18% -$8.05K ﹤0.01% 1555
2024
Q3 		$44.6K Buy
845
+258
+44% +$14.4K ﹤0.01% 1467
2024
Q2 		$31.8K Sell
587
-69
-11% -$4.17K ﹤0.01% 1558
2024
Q1 		$46K Buy
656
+318
+94% +$24.6K ﹤0.01% 1371
2023
Q4 		$28.2K Sell
338
-21
-6% -$760 ﹤0.01% 1643
2023
Q3 		$10.6K Sell
359
-53
-13% -$1.76K ﹤0.01% 1940
2023
Q2 		$13.4K Buy
412
+115
+39% +$4.25K ﹤0.01% 1888
2023
Q1 		$10.5K Buy
297
+35
+13% +$1.43K ﹤0.01% 2083
2022
Q4 		$12K Buy
262
+11
+4% +$473 ﹤0.01% 1891
2022
Q3 		$12K Hold
251
– – ﹤0.01% 1867
2022
Q2 		$10K Buy
251
+3
+1% +$121 ﹤0.01% 1988
2022
Q1 		$9K Buy
248
+37
+18% +$1.31K ﹤0.01% 2087
2021
Q4 		$10K Buy
211
+97
+85% +$3.74K ﹤0.01% 2082
2021
Q3 		$4K Buy
+114
New +$3.36K ﹤0.01% 2251
2019
Q4 		– Sell
-482
Closed -$5K – 2227
2019
Q3 		$5K Buy
+482
New +$6.05K ﹤0.01% 1924
2015
Q1 		– Sell
-2,000
Closed -$16K – 2798
2014
Q4 		$16K Hold
2,000
– – ﹤0.01% 1785
2014
Q3 		$7K Hold
2,000
– – ﹤0.01% 2090
2014
Q2 		$10K Buy
+2,000
New +$12.2K ﹤0.01% 2009

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fifth Third Bancorp's CYTK Position: Q2 2026 in Review

Fifth Third Bancorp increased its Cytokinetics (CYTK) stake by 5.5% in Q2 2026, buying an estimated $113K and bringing the position to 30,303 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1132.

Fifth Third Bancorp first reported a position in CYTK in Q2 2014 and has held it in 24 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Fifth Third Bancorp held 30,303 shares of Cytokinetics worth $2.58M as of Q2 2026.
  • Fifth Third Bancorp bought 1,575 Cytokinetics shares in Q2 2026, an estimated $113K.
  • Cytokinetics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1132 holding.
  • Fifth Third Bancorp first reported a position in Cytokinetics in Q2 2014 and has held it in 24 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.